|
|
Pfizer Inc. is in early talks to acquire drugmaker
Seagen Inc., the Wall Street Journal reported late on Sunday, citing people
familiar with the matter. Seagen has a market value of some $30 billion and
would be expected to command a premium over that, the report said, adding
that the deal talks are in preliminary stages. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Monday, February 27, 2023
Seagen Inc. To Be Acquired By Pfizer for $30 Billion
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment